I should have asked: Does Apple's license make it harder for someone else to challenge the patent? I assumed it would, but if I'm reading MedImmune v. Genentec

I should have asked: Does Apple's license make it harder for someone else to challenge the patent? I assumed it would, but if I'm reading MedImmune v. Genentech correctly then it doesn't even make it harder for Apple to challenge.